vs
BLACK HILLS CORP（BKH）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是BLACK HILLS CORP的1.2倍（$772.1M vs $622.7M），BLACK HILLS CORP净利率更高（16.8% vs 12.7%，领先4.1%），BLACK HILLS CORP同比增速更快（6.4% vs 5.9%），Revvity自由现金流更多（$161.8M vs $-101.5M），过去两年Revvity的营收复合增速更高（9.0% vs -6.8%）
布莱克山集团是美国多元化能源企业，总部位于南达科他州拉皮德城，名称来源于当地的布莱克山区域。公司主营电力与天然气公用事业，服务覆盖南达科他、蒙大拿、怀俄明、科罗拉多等多个州，电力产品行销整个美国西部地区。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
BKH vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.2倍
$622.7M
营收增速更快
BKH
高出0.6%
5.9%
净利率更高
BKH
高出4.1%
12.7%
自由现金流更多
RVTY
多$263.3M
$-101.5M
两年增速更快
RVTY
近两年复合增速
-6.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $622.7M | $772.1M |
| 净利润 | $104.9M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 27.5% | 14.5% |
| 净利率 | 16.8% | 12.7% |
| 营收同比 | 6.4% | 5.9% |
| 净利润同比 | 7.0% | 3.9% |
| 每股收益（稀释后） | $1.39 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BKHRVTY
| Q4 25 | $622.7M | $772.1M | ||
| Q3 25 | $427.4M | $698.9M | ||
| Q2 25 | $435.7M | $720.3M | ||
| Q1 25 | $800.4M | $664.8M | ||
| Q4 24 | $585.1M | $729.4M | ||
| Q3 24 | $398.6M | $684.0M | ||
| Q2 24 | $397.1M | $691.7M | ||
| Q1 24 | $717.2M | $649.9M |
净利润BKHRVTY
| Q4 25 | $104.9M | $98.4M | ||
| Q3 25 | $24.9M | $46.7M | ||
| Q2 25 | $27.5M | $53.9M | ||
| Q1 25 | $134.3M | $42.2M | ||
| Q4 24 | $98.0M | $94.6M | ||
| Q3 24 | $24.4M | $94.4M | ||
| Q2 24 | $22.8M | $55.4M | ||
| Q1 24 | $127.9M | $26.0M |
毛利率BKHRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率BKHRVTY
| Q4 25 | 27.5% | 14.5% | ||
| Q3 25 | 18.4% | 11.7% | ||
| Q2 25 | 18.9% | 12.6% | ||
| Q1 25 | 25.6% | 10.9% | ||
| Q4 24 | 27.9% | 16.3% | ||
| Q3 24 | 19.0% | 14.3% | ||
| Q2 24 | 17.8% | 12.4% | ||
| Q1 24 | 27.0% | 6.8% |
净利率BKHRVTY
| Q4 25 | 16.8% | 12.7% | ||
| Q3 25 | 5.8% | 6.7% | ||
| Q2 25 | 6.3% | 7.5% | ||
| Q1 25 | 16.8% | 6.4% | ||
| Q4 24 | 16.7% | 13.0% | ||
| Q3 24 | 6.1% | 13.8% | ||
| Q2 24 | 5.7% | 8.0% | ||
| Q1 24 | 17.8% | 4.0% |
每股收益（稀释后）BKHRVTY
| Q4 25 | $1.39 | $0.86 | ||
| Q3 25 | $0.34 | $0.40 | ||
| Q2 25 | $0.38 | $0.46 | ||
| Q1 25 | $1.87 | $0.35 | ||
| Q4 24 | $1.36 | $0.77 | ||
| Q3 24 | $0.35 | $0.77 | ||
| Q2 24 | $0.33 | $0.45 | ||
| Q1 24 | $1.87 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $182.8M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.8B | $7.3B |
| 总资产 | $10.9B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BKHRVTY
| Q4 25 | $182.8M | $919.9M | ||
| Q3 25 | $21.1M | $931.4M | ||
| Q2 25 | $8.1M | $991.8M | ||
| Q1 25 | $6.6M | $1.1B | ||
| Q4 24 | $16.1M | $1.2B | ||
| Q3 24 | $12.5M | $1.2B | ||
| Q2 24 | $624.8M | $2.0B | ||
| Q1 24 | $123.0M | $1.7B |
股东权益BKHRVTY
| Q4 25 | $3.8B | $7.3B | ||
| Q3 25 | $3.8B | $7.4B | ||
| Q2 25 | $3.6B | $7.6B | ||
| Q1 25 | $3.6B | $7.6B | ||
| Q4 24 | $3.5B | $7.7B | ||
| Q3 24 | $3.4B | $7.9B | ||
| Q2 24 | $3.4B | $7.9B | ||
| Q1 24 | $3.3B | $7.8B |
总资产BKHRVTY
| Q4 25 | $10.9B | $12.2B | ||
| Q3 25 | $10.3B | $12.1B | ||
| Q2 25 | $10.1B | $12.4B | ||
| Q1 25 | $10.1B | $12.4B | ||
| Q4 24 | $10.0B | $12.4B | ||
| Q3 24 | $9.7B | $12.8B | ||
| Q2 24 | $10.2B | $13.4B | ||
| Q1 24 | $9.7B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $168.1M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $-101.5M | $161.8M |
| 自由现金流率自由现金流/营收 | -16.3% | 21.0% |
| 资本支出强度资本支出/营收 | 43.3% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.60× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $-146.4M | $509.4M |
8季度趋势，按日历期对齐
经营现金流BKHRVTY
| Q4 25 | $168.1M | $182.0M | ||
| Q3 25 | $88.9M | $138.5M | ||
| Q2 25 | $188.6M | $134.3M | ||
| Q1 25 | $227.8M | $128.2M | ||
| Q4 24 | $153.2M | $174.2M | ||
| Q3 24 | $102.1M | $147.9M | ||
| Q2 24 | $230.6M | $158.6M | ||
| Q1 24 | $233.4M | $147.6M |
自由现金流BKHRVTY
| Q4 25 | $-101.5M | $161.8M | ||
| Q3 25 | $-89.5M | $120.0M | ||
| Q2 25 | $-30.3M | $115.5M | ||
| Q1 25 | $74.9M | $112.2M | ||
| Q4 24 | $-60.5M | $149.8M | ||
| Q3 24 | $-86.0M | $125.6M | ||
| Q2 24 | $64.4M | $136.6M | ||
| Q1 24 | $57.2M | $129.7M |
自由现金流率BKHRVTY
| Q4 25 | -16.3% | 21.0% | ||
| Q3 25 | -20.9% | 17.2% | ||
| Q2 25 | -7.0% | 16.0% | ||
| Q1 25 | 9.4% | 16.9% | ||
| Q4 24 | -10.3% | 20.5% | ||
| Q3 24 | -21.6% | 18.4% | ||
| Q2 24 | 16.2% | 19.7% | ||
| Q1 24 | 8.0% | 20.0% |
资本支出强度BKHRVTY
| Q4 25 | 43.3% | 2.6% | ||
| Q3 25 | 41.7% | 2.6% | ||
| Q2 25 | 50.2% | 2.6% | ||
| Q1 25 | 19.1% | 2.4% | ||
| Q4 24 | 36.5% | 3.4% | ||
| Q3 24 | 47.2% | 3.3% | ||
| Q2 24 | 41.9% | 3.2% | ||
| Q1 24 | 24.6% | 2.7% |
现金转化率BKHRVTY
| Q4 25 | 1.60× | 1.85× | ||
| Q3 25 | 3.57× | 2.97× | ||
| Q2 25 | 6.86× | 2.49× | ||
| Q1 25 | 1.70× | 3.03× | ||
| Q4 24 | 1.56× | 1.84× | ||
| Q3 24 | 4.18× | 1.57× | ||
| Q2 24 | 10.11× | 2.87× | ||
| Q1 24 | 1.82× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BKH
| Gas Utilities | $391.1M | 63% |
| Retail Electric Natural Gasand Coal | $189.7M | 30% |
| Other | $15.3M | 2% |
| Market Off System Sales | $13.6M | 2% |
| Transferred At Point In Time | $8.9M | 1% |
| Wholesale | $4.9M | 1% |
| Inter Segment Revenues | $2.4M | 0% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
